Niacin (Vitamin B3) Lowers High Cholesterol Safely

Niacin (Vitamin B3) Lowers High Cholesterol Safely

OMNS - There is a safe, inexpensive, nonprescription, convenient and effective way to reduce high cholesterol levels and reduce heart disease risk: niacin. Niacin is a water-soluble B-complex vitamin, vitamin B-3. One of niacin's unique properties is its ability to help you naturally relax and to fall asleep more rapidly at night. It is well established that niacin helps reduce harmful cholesterol levels in the bloodstream. Niacin is one of the best substances for elevating high density lipoprotein cholesterol (the "good cholesterol) and so decreases the ratio of the total cholesterol over high density cholesterol.

The finding that niacin lowered cholesterol was soon confirmed by Parsons, Achor, Berge, McKenzie and Barker (1956) and Parsons (1961, 1961a, 1962) at the Mayo Clinic, which launched niacin on its way as a hypocholesterolemic substance. Since then it has been found to be a normalizing agent, meaning it elevates high density lipoprotein cholesterol, decreases low density and very low density lipoprotein cholesterol and lowers triglycerides. Grundy, Mok, Zechs and Berman (1981) found it lowered cholesterol by 22 percent and triglycerides by 52 percent and wrote, "To our knowledge, no other single agent has such potential for lowering both cholesterol and triglycerides."

Elevated cholesterol levels are associated with increased risk of developing coronary disease. In addition to niacin, a typical diet generally recommended by orthomolecular physicians will tend to keep cholesterol levels down in most people. This diet can be described as a high fiber, sugar-free diet which is rich in complex polysaccharides such as vegetables and whole grains.

With adequately high doses of niacin, it is possible to lower cholesterol levels even with no alteration in diet. E. Boyle, then working with the National Institutes of Health in Washington, D.C., quickly became interested in niacin. He began to follow a series of patients using 3 grams (3,000 milligrams) of niacin per day. He reported his conclusions in a document prepared for physicians involved in Alcoholics Anonymous by Bill W (1968). In this report, Boyle reported that he had kept 160 coronary patients on niacin for ten years. Only six died, against a statistical expectation that 62 would have died with conventional care. He stated, "From the strictly medical viewpoint I believe all patients taking niacin would survive longer and enjoy life much more." His prediction came true when the National Coronary Drug Study was evaluated by Canner recently. But Boyle's data spoke for itself. Continuous use of niacin will decrease mortality and prolong life. Continue reading >>

VITAMIN C KILLS CANCER CELLS

VITAMIN C KILLS CANCER CELLS

Intravenous Vitamin C is Selectively Toxic to Cancer Cells

(OMNS) National Institutes of Health scientists have confirmed the concepts that vitamin C is selectively toxic to cancer cells and that tumor-toxic levels of vitamin C can be attained using intravenous administration. The article, published in the September 12, 2005 issue of the Proceedings of the National Academy of Sciences (1) concluded, “These findings give plausibility to intravenous ascorbic acid in cancer treatment.”

Orthomolecular medical researchers, including Nobel laureate Linus Pauling, have long recognized the great importance of vitamin C in fighting cancer. (2) Scientists associated with the Bio-Communications Research Institute (BRCI) in Wichita, Kansas have published 20 scientific articles on the subject. (3) BCRI researchers first reported in 1995 that vitamin C in sufficient amounts is selectively toxic to tumor cells. The authors concluded that tumor-toxic levels of vitamin C could be achieved only by giving the vitamin intravenously. Subsequent research from BCRI, published in the British Journal of Cancer in 2001 (4), was the first to describe in detail the pharmacokinetics of high doses of intravenous vitamin C.

"It is gratifying to have our research on vitamin C and cancer confirmed by scientists at the prestigious National Institutes of Health," said Neil Riordan, Ph.D., BCRI’s Research Director. “The findings reinforce our goal and commitment to pursue cutting edge cancer research,” added Michael Gonzalez, Ph.D., D.Sc. of the University of Puerto Rico.

BCRI’s vitamin C research was headed by its founder Hugh D. Riordan, M.D. The research team includes Dr. Xiaolong Meng, Dr. Joseph Casciari, Dr. Nina Mikirova, Dr. Jie Zhong, Dr. James A. Jackson, Dr. Don Davis, Dr. Jorge Miranda, Dr. Michael Gonzalez, Dr. Neil Riordan, and Mr. Paul Taylor.

What is Orthomolecular Medicine?

Linus Pauling defined orthomolecular medicine as "the treatment of disease by the provision of the optimum molecular environment, especially the optimum concentrations of substances normally present in the human body." Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information:http://www.orthomolecular.org/
Continue reading >>

Orthomolecular medicine was developed by Linus Pauling

Orthomolecular medicine was developed by Linus Pauling

Orthomolecular medicine was developed by Linus Pauling, Ph.D., winner of two Nobel prizes, in 1968. It is designed to enable individuals to reach the apex of health and the peak of their performance by utilizing only naturally occurring substances (e.g. vitamins, minerals, enzymes, trace elements, co-enzymes). The proper balance of these substances in the body is the key to reaching physical, mental, and emotional health and stability. Orthomolecular medicine can be used therapeutically to treat diseases such as cancer and AIDS, or preventatively to impede the progress of degenerative disease and aging. When all is said and done, however, the main objective of orthomolecular medicine is to help the patient reach an optimal level of health; his or her self-esteem will probably improve in the process. 

Although orthomolecular medicine did not fully develop into a therapy until the late 1960's when Pauling coined the term "orthomolecular," the premise behind this practice originated in the 1920's, when vitamins and minerals were first used to treat illnesses unrelated to nutrient deficiency. It was discovered that vitamin A could prevent childhood deaths from infectious illness, and that heart arrhythmia (irregular heartbeat) could be stopped by dosages of magnesium. Hard scientific evidence supporting nutritional therapy did not emerge, however, until the 1950's, when Abram Hoffer, M.D., and Humphrey Osmond, M.D., began treating schizophrenics with high doses of vitamin B3 (niacin). As a consequence of their studies, it was revealed that niacin, in combination with other medical treatments, could double the number of recoveries in a one-year period. 

Eventually, it was determined that malnutrition and consumption of refined, empty-calorie foods such as white bread and pastries and overconsumption of sugar could yield disease and psychiatric disorders. It became apparent that a person's diet was an overwhelmingly integral part of his or her health and well-being. Further studies showed that decreased intake of dietary fiber, bran, minerals, and complex carbohydrates was prevalent in patients with certain forms of mental illness, accompanied by a loss of vitamins and an increase in dietary fat. 

Biochemical individual is a main principle of orthomolecular medicine. This principle was elucidated by Roger J. Williams, Ph.D. This principle is quite simple: every living organism is unique! Furthermore, each individual requires different relative amounts of nutrients for his or her satisfaction and optimal level of health. The government sets a minimum recommended daily allowance (RDA) which is supposed to be adequate for all individuals. However, many may need to exceed the RDA as well as the recommended 2,000 calorie diet in order to prevent severe deficiency disease. Thus, RDA values are not perfect guidelines for everyone. Several studies have proven the existence of biochemical individuality. For example, studies of guinea pigs showed a twentyfold variation in their requirement for vitamin C. A study conducted with human subjects revealed that children have varying needs for vitamin B6. Read more